P. Kaur

发表

A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab

N. Zhang, M. Moxness, A. Kaliyaperumal, 2016, Annals of the rheumatic diseases.

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

N. Freemantle, D. Kendler, J. Borenstein, 2011, Osteoporosis International.

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

N. Freemantle, M. McClung, D. Kendler, 2011, Osteoporosis International.

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study

Stanley B. Cohen, M. Genovese, N. Zhang, 2017, Annals of the rheumatic diseases.

Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports

P. Kaur, S. Berney, Virginia C. Chan, 2008, Clinical Rheumatology.

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

E. Israel, C. Brightling, G. Colice, 2021, The New England journal of medicine.

Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

E. Israel, G. Colice, G. Chupp, 2021 .

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

G. Colice, A. Menzies-Gow, M. Mo, 2020, Respiratory Research.

Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study

R. Horne, D. Kendler, R. Wagman, 2014, Menopause.

B. Strober, N. Zhang, A. Costanzo, 2017, Journal of the American Academy of Dermatology.

Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy.

R. DeHoratius, P. Kaur, C. Derk, 2004, The Journal of rheumatology.

Successful etanercept use in an HIV-positive patient with rheumatoid arthritis.

P. Kaur, S. Berney, Virginia C. Chan, 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Manufacturing of Biologics

M. Ramchandani, P. Kaur, Jared J. Nathan, 2018 .

Infiltration of histiocytes and multinucleated giant cells in the myocardium of a patient with multicentric reticulohistiocytosis.

H. Sasken, P. Kaur, Tamika A. Webb-Detiege, 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

B. Strober, A. Costanzo, N. Zhang, 2017, The British journal of dermatology.

AMG 151 (ARRY‐403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes

S. Mudaliar, P. Raskin, J. Sierra-johnson, 2016, Diabetes, obesity & metabolism.

Microscopic polyangiitis presenting as early cardiac tamponade.

P. Kaur, Humaira Hussain, Aniruddha Palya, 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community

T. Born, Jennifer Liu, M. Ramchandani, 2017, BioDrugs.

Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community

T. Born, Jennifer Liu, M. Ramchandani, 2017, BioDrugs.

Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators

V. Strand, J. Jansen, D. Incerti, 2017, Journal of medical economics.

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

P. Kaur, Sophia Li, S. Berney, 2009, Clinical Rheumatology.

Rosai-Dorfman disease in a patient with systemic lupus erythematosus.

R. DeHoratius, P. Kaur, R. Birbe, 2005, The Journal of rheumatology.

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.

P. Kuna, T. Welte, C. Brightling, 2022, The Lancet. Respiratory medicine.

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

G. Colice, M. Wechsler, M. Mo, 2020, Respiratory Research.

J. Crowley, L. Spelman, P. Kaur, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

P132 Design of an adaptive, phase 2, placebo-controlled, dose-ranging study to assess the efficacy and safety of AMG 570 in subjects with active SLE and inadequate response to standard of care therapy

R. Lenz, Tony Jiang, Laurence E. Cheng, 2020 .

Effects of methotrexate use in a patient with rheumatoid arthritis and multiple sclerosis.

P. Kaur, Sophia Li, S. Berney, 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.